INSIGHTS ON QUALITY CONTROL

• 8 Regulations Every Biotech & Pharma Quality Leader Must Know

  Navigate essential biotech and pharma regulations safely. Learn how unifying global standards streamlines audits and accelerates development schedules.

• Top Questions Before You Buy A Hazardous Pharmacy Compounding Isolator

  Move beyond brochure specifications for hazardous compounding. Learn the critical airflow, structural, and pressure requirements needed to ensure long-term facility safety.

• CMC (Chemistry, Manufacturing and Controls) Management

  Eliminate regulatory risks caused by fragmented data. Learn how a continuous data thread from bench to batch streamlines tech transfer and accelerates filing timelines.

• Platform Strategy For Improving Manufacturability And Efficacy In Bispecific Antibodies

  Novel bispecific antibody engineering overcomes assembly and manufacturability challenges, enabling scalable production while preserving therapeutic function, stability, purity, and product quality.

• Extraction And Chemical Characterization Pitfalls In Complex Medical Devices

  8/20/2026

  Standard extraction protocols routinely fail tissue-derived products, hydrogels, absorbables, and silicone implants. Learn the material-specific study design strategies that prevent regulatory rejection and repeat work.

• GMP Compliance In Pharmaceutical Manufacturing: Why Product Inspection Matters

  9/17/2026

  Learn how integrating advanced inspection technology—including X-ray systems, metal detectors, and checkweighers—can optimize your compliance strategy and protect product quality.

• Your Guide To Precise And Robust Separation Methods

  11/12/2025

  Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.

• Understanding cGMPs For Phase 1 Investigational Drugs

  8/15/2025

  Learn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.

• A CDMO's Take On Psychedelic Formulation

  1/26/2026

  Psychedelics show therapeutic promise, but face major formulation and regulatory hurdles. Advances in delivery and neuroscience may unlock new mental‑health treatments.